SCHEMBL185378

SCHEMBL185378

CCC=CCC=CCC=CCCCCC=CCCCC(=O)O

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.96
PPARG P37231 8/20 0.96
F7 P08709 7/20 0.96
F3 P13726 7/20 0.96
CYP19A1 P11511 6/20 0.96
PPARD Q03181 6/20 0.96
PPARA Q07869 6/20 0.96
PTGS1 P23219 5/20 0.96
OXER1 Q8TDS5 4/20 0.96
KMT2A Q03164 3/20 0.96
RXRA P19793 2/20 0.96
ADORA3 P0DMS8 1/20 0.96
FFAR1 O14842 5/20 0.89
MAPT P10636 4/20 0.89
L3MBTL1 Q9Y468 3/20 0.89
KDM4E B2RXH2 3/20 0.89
LMNA P02545 3/20 0.89
CYP3A4 P08684 3/20 0.89
HPGD P15428 3/20 0.89
ALOX15 P16050 3/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4162358 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL185377 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL6119205 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL23698111 0.98 ALDH1A1 (0.93) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL31189049 0.98 ALDH1A1 (0.93) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL23698109 0.98 ALDH1A1 (0.93) ALDH1A1PPARGF7F3CYP19A1
Icosapent SCHEMBL18274961 0.98 ALDH1A1 (1.00) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL23417014 0.98 ALDH1A1 (1.00) ALDH1A1PPARGF7F3CYP19A1
Icosapent SCHEMBL2877002 0.98 ALDH1A1 (1.00) ALDH1A1PPARGF7F3CYP19A1
Icosapent SCHEMBL18185494 0.98 ALDH1A1 (1.00) ALDH1A1PPARGF7F3CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11628152-B2 Lipid compositions containing bioactive fatty acids SCIADONICS, INC. (US) 2023-04-18 US claimed
US-20210308088-A1 LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS SCIADONICS, INC. 2021-10-07 US claimed
US-10980763-B2 Lipid compositions containing bioactive fatty acids SCIADONICS, INC. (US) 2021-04-20 US claimed
US-20200164110-A1 LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS SCIADONICS, INC. 2020-05-28 US claimed
US-20160022622-A1 LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS SCIADONICS, INC. 2016-01-28 US claimed
EP-0777641-A1 ANTI-INFLAMMATORY PREPARATION J.W. BROADBENT NOMINEES PTY. LTD. (AU) 1997-06-11 EP claimed
WO-1996005164-A1 ANTI-INFLAMMATORY PREPARATION J.W. BROADBENT NOMINEES PTY. LTD. (AU) 1996-02-22 WO claimed
JP-5276964-A None JP disclosed
JP-5276964-A None JP disclosed
US-20250195352-A1 LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS SCIADONICS, INC. 2025-06-19 US disclosed
CN-120053661-A Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof 太阳雨林(北京)生物医药有限公司 2025-05-30 CN disclosed
CN-120053660-A Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof 太阳雨林(北京)生物医药有限公司 2025-05-30 CN disclosed
CN-119855607-A Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application 太阳雨林(北京)生物医药有限公司 2025-04-18 CN disclosed
EP-0777641-A1 ANTI-INFLAMMATORY PREPARATION J.W. BROADBENT NOMINEES PTY. LTD. (AU) 1997-06-11 EP disclosed
WO-1996005164-A1 ANTI-INFLAMMATORY PREPARATION J.W. BROADBENT NOMINEES PTY. LTD. (AU) 1996-02-22 WO disclosed
WO-1996005164-A1 ANTI-INFLAMMATORY PREPARATION J.W. BROADBENT NOMINEES PTY. LTD. (AU) 1996-02-22 WO disclosed
US-5456912-A Non-methylene interrupted fatty acids as immunomodulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-10-10 US disclosed
WO-1995017897-A1 NON-METHYLENE INTERRUPTED FATTY ACIDS AS IMMUNOMODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-07-06 WO disclosed
JP-H05276964-A PRODUCTION OF 5,11,14-EICOSATETRAENOIC ACID, 5,11,14,17-EICOSATETRAENOIC ACID AND LIPID CONTAINING THESE ACIDS SUNTORY LTD 1993-10-26 JP disclosed
JP-H05276964-A PRODUCTION OF 5,11,14-EICOSATETRAENOIC ACID, 5,11,14,17-EICOSATETRAENOIC ACID AND LIPID CONTAINING THESE ACIDS SUNTORY LTD 1993-10-26 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250195352-A1 LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS SGMS2, ALOX12, ALOX15 ALDH1A1 2137/4885PPARG 262/4885F7 2066/4885
US-20210308088-A1 LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS ALOX5, ALOX15B, FASN ALDH1A1 3063/4885PPARG 307/4885F7 618/4885
US-11628152-B2 Lipid compositions containing bioactive fatty acids ALOX5, ALOX15B, FASN ALDH1A1 3063/4885PPARG 307/4885F7 618/4885
US-10980763-B2 Lipid compositions containing bioactive fatty acids ALOX5, ALOX15B, FASN ALDH1A1 3063/4885PPARG 307/4885F7 618/4885
US-20160022622-A1 LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS ALOX5, ALOX15B, FASN ALDH1A1 3063/4885PPARG 307/4885F7 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.